Salem Health Cancer Institute is a sub-site for OHSU's GRAIL PATHFINDER 2 study. This is a clinical trial to improve cancer early detection. Eligible participants will receive a simple blood test that may detect many types of cancer. Appointments can be scheduled at Salem Health Cancer Institute in Building C.
For more information and to see if you qualify, please click here and share with your family and friends!